WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke TREGING wurde als Wortmarke am 21.09.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1578172 |
| Länder | 
|
| Basismarke |
Nr. 90175258,
11. September 2020
|
| Anmeldedatum | 21. September 2020 |
| Ablaufdatum | 21. September 2030 |
Markeninhaber
704 Quince Orchard Rd. Suite 160
Gaithersburg MD 20878
US
Gaithersburg MD 20878
US
Markenvertreter
379 Lytton Avenue
Palo Alto CA 94301
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of autoimmune
diseases and conditions; pharmaceutical preparations for the
treatment of hemophilia; pharmaceutical preparations for the
treatment of cancer and tumors; pharmaceutical preparations
for the treatment of multiple sclerosis, atopic dermatitis,
anti-drug antibody formation and xenotransplantation;
pharmaceutical preparations for use in immunotherapy,
namely, regulatory t-cell therapy
40
Manufacturing services for pharmaceutical products (Terms
too vague in the opinion of the International Bureau – Rule
13 (2) (b) of the Regulations); providing technical
information in the field of pharmaceutical manufacturing;
custom manufacturing of pharmaceuticals
42
Medical and pharmaceutical research and development
services; scientific research and development services in
the medical field; providing medical and scientific
information in the medical field; providing medical and
scientific research information in the field of
pharmaceuticals and clinical trials; scientific research and
development services in the field of regulatory t-cell and
chimeric antigen receptor therapy; scientific research and
development services in the field of new cancer therapies;
medical and veterinary research services, namely, the
manipulation of cells within a laboratory or research
facility to enable the cells to be used for therapeutic
purposes; scientific research in human and animal gene
therapy; scientific research into vectors and preparations
for manipulating and adapting human and animal cells;
consultancy relating to all the aforesaid services
44
Providing medical information in the field of
pharmaceuticals, autoimmune diseases and conditions,
hemophilia, cancer, multiple sclerosis, atopic dermatitis,
anti-drug antibody formation and xenotransplantation;
providing a website featuring information in the medical
field and in the field of pharmaceuticals, autoimmune
diseases and conditions, hemophilia, cancer, multiple
sclerosis, atopic dermatitis, anti-drug antibody formation
and xenotransplantation (Terms too vague in the opinion of
the International Bureau – Rule 13 (2) (b) of the
Regulations); consulting in the field of pharmaceuticals,
autoimmune diseases and conditions, hemophilia, cancer,
multiple sclerosis, atopic dermatitis, anti-drug antibody
formation and xenotransplantation; medical services;
veterinary services; medical services in the extraction of
human and animal cells from patients; manipulation of human
and animal cells for therapeutic purposes; reinsertion of
cells into human and animal patients for medical purposes;
providing medical and therapy advice and consultancy in the
field of medical and veterinary therapies; providing cancer
therapy advice and consultancy; providing information
relating to diagnostic, prophylactic and therapeutic
properties of pharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 17. August 2022 | 2022/34 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. Juni 2022 | 2022/32 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 19. Mai 2022 | 2022/21 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. Januar 2022 | 2022/6 Gaz | CH | Ablehnung |
| 07. Januar 2022 | 2022/2 Gaz | JP | Ablehnung |
| 14. Dezember 2021 | 2021/51 Gaz | KR | Ablehnung |
| 16. September 2021 | 2021/37 Gaz | GB | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 27. Juli 2021 | 2021/32 Gaz | EM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. Juni 2021 | 2021/25 Gaz | CN | Ablehnung |
| 27. April 2021 | 2021/18 Gaz | GB | Ablehnung |
| 11. März 2021 | 2021/11 Gaz | EM | Ablehnung |
| 21. September 2020 | 2021/7 Gaz | US | Eintragung |
ID: 141578172